{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:35:14Z","timestamp":1792607714524,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.neurobiolaging.2021.11.001","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T10:59:10Z","timestamp":1636628350000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Comparing anti\u2013aging hallmark activities of Metformin and Nano-PSO in a mouse model of genetic Creutzfeldt-Jakob Disease"],"prefix":"10.1016","volume":"110","author":[{"given":"Orli","family":"Binyamin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Frid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Saada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Gabizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0001","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2019.12.074","article-title":"Metformin reduces prion infection in neuronal cells by enhancing autophagy","volume":"523","author":"Abdelaziz","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21093240","article-title":"The metformin mechanism on gluconeogenesis and AMPK activation: the metabolite perspective","volume":"21","author":"Agius","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0003","doi-asserted-by":"crossref","DOI":"10.1177\/1533317519899546","article-title":"Antidiabetic drugs for the risk of alzheimer disease in patients with type 2 DM using FAERS","volume":"35","author":"Akimoto","year":"2020","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"17","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0004","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.4161\/cc.7.17.6625","article-title":"Metformin slows down aging and extends life span of female SHR mice","volume":"7","author":"Anisimov","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-1-4614-3573-0_13","article-title":"Cytochrome c oxidase and its role in neurodegeneration and neuroprotection","volume":"748","author":"Arnold","year":"2012","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0006","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","article-title":"Metformin as a tool to target aging","volume":"23","author":"Barzilai","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0007","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.nbd.2017.08.012","article-title":"Continues administration of Nano-PSO significantly increased survival of genetic CJD mice","volume":"108","author":"Binyamin","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0008","first-page":"7165","article-title":"Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant","volume":"10","author":"Binyamin","year":"2015","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0009","doi-asserted-by":"crossref","first-page":"18437","DOI":"10.1038\/s41598-019-54971-9","article-title":"Brain targeting of 9c,11t-conjugated linoleic acid, a natural calpain inhibitor, preserves memory and reduces Abeta and P25 accumulation in 5XFAD mice","volume":"9","author":"Binyamin","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0891988710383576","article-title":"The prion diseases","volume":"23","author":"Brown","year":"2010","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101343","article-title":"Hypoxia and brain aging: neurodegeneration or neuroprotection?","volume":"68","author":"Burtscher","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0012","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cell.2013.02.035","article-title":"Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism","volume":"153","author":"Cabreiro","year":"2013","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000977","article-title":"Oxidation of helix-3 methionines precedes the formation of PK resistant PrP","volume":"6","author":"Canello","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113043","article-title":"AMPK: a bridge between diabetes mellitus and Alzheimer's disease","volume":"400","author":"Chen","year":"2021","journal-title":"Behav Brain Res"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0015","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3109\/10715762.2012.714466","article-title":"Are oxidative stress and mitochondrial dysfunction the key players in the neurodegenerative diseases?","volume":"46","author":"Di Carlo","year":"2012","journal-title":"Free Radic Res"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0016","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0196-9781(02)00068-2","article-title":"Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases","volume":"23","author":"Diaz-Nido","year":"2002","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0017","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1073\/pnas.73.2.630","article-title":"The mucopolysaccharidoses (a review)","volume":"73","author":"Dorfman","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0018","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/cells10020452","article-title":"Upregulation of COX4-2 via HIF-1alpha in mitochondrial COX4-1 deficiency","volume":"10","author":"Douiev","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0019","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/acel.12171","article-title":"A novel inhibitor of the insulin\/IGF signaling pathway protects from age-onset, neurodegeneration-linked proteotoxicity","volume":"13","author":"El-Ami","year":"2014","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/hsz-2015-0295","article-title":"Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function","volume":"397","author":"Esteras","year":"2016","journal-title":"Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0021","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fnins.2016.00510","article-title":"Chronic progressive neurodegeneration in a transgenic mouse model of prion disease","volume":"10","author":"Fainstein","year":"2016","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0022","doi-asserted-by":"crossref","first-page":"e12765","DOI":"10.1111\/acel.12765","article-title":"Metformin alleviates human cellular aging by upregulating the endoplasmic reticulum glutathione peroxidase 7","volume":"17","author":"Fang","year":"2018","journal-title":"Aging Cell"},{"issue":"18","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0023","doi-asserted-by":"crossref","first-page":"e00524","DOI":"10.1128\/JVI.00524-17","article-title":"Mitochondrial respiration is impaired during late-stage hamster prion infection","volume":"91","author":"Faris","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0024","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neurobiolaging.2018.01.004","article-title":"Autologous neural progenitor cell transplantation into newborn mice modeling for E200K genetic prion disease delays disease progression","volume":"65","author":"Frid","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neurobiolaging.2020.07.030","article-title":"Delay of gCJD aggravation in sick TgMHu2ME199K mice by combining NPC transplantation and Nano-PSO administration","volume":"95","author":"Frid","year":"2020","journal-title":"Neurobiol Aging"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002350","article-title":"Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease","volume":"7","author":"Friedman-Levi","year":"2011","journal-title":"PLoS Pathog"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0027","doi-asserted-by":"crossref","first-page":"e69583","DOI":"10.1371\/journal.pone.0069583","article-title":"PrP(ST), a soluble, protease resistant and truncated PrP form features in the pathogenesis of a genetic prion disease","volume":"8","author":"Friedman-Levi","year":"2013","journal-title":"PLoS One"},{"issue":"6046","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0028","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.1201940","article-title":"Mitochondria and the autophagy-inflammation-cell death axis in organismal aging","volume":"333","author":"Green","year":"2011","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0029","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.1038\/s41598-021-86905-9","article-title":"Metformin prevents stroke damage in non-diabetic female mice with chronic kidney disease","volume":"11","author":"Grissi","year":"2021","journal-title":"Sci Rep"},{"issue":"17","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0030","doi-asserted-by":"crossref","first-page":"17057","DOI":"10.1074\/jbc.M411314200","article-title":"PrPSc incorporation to cells requires endogenous glycosaminoglycan expression","volume":"280","author":"Hijazi","year":"2005","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0031","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cmet.2016.12.009","article-title":"Metformin inhibits hepatic mTORC1 signaling via dose-dependent mechanisms involving AMPK and the TSC complex","volume":"25","author":"Howell","year":"2017","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0032","doi-asserted-by":"crossref","first-page":"480","DOI":"10.14336\/AD.2020.0702","article-title":"Metformin: a potential candidate for targeting aging mechanisms","volume":"12","author":"Hu","year":"2021","journal-title":"Aging Dis"},{"issue":"21","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0033","doi-asserted-by":"crossref","first-page":"16023","DOI":"10.1074\/jbc.275.21.16023","article-title":"Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages","volume":"275","author":"Ishii","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0034","first-page":"1","article-title":"Urinary sulphated glycosaminoglycans excretion in obese patients with type 2 diabetes mellitus treated with metformin","author":"Jura-Poltorak","year":"2019","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101211","article-title":"The role of Nrf2 in neural stem\/progenitors cells: From maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease","volume":"65","author":"Kahroba","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0036","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ymgme.2020.02.006","article-title":"Urinary glycosaminoglycans as a potential biomarker for evaluating treatment efficacy in subjects with mucopolysaccharidoses","volume":"130","author":"Kakkis","year":"2020","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0037","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.nbd.2018.11.003","article-title":"Mitochondrial dysfunction in preclinical genetic prion disease: a target for preventive treatment?","volume":"124","author":"Keller","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0038","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2020.03.004","article-title":"Advances in glycosaminoglycan detection","volume":"130","author":"Khan","year":"2020","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108496","article-title":"Metformin use in elderly population with diabetes reduced the risk of dementia in a dose-dependent manner, based on the Korean NHIS-HEALS cohort","volume":"170","author":"Kim","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/db07-0381","article-title":"Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP","volume":"57","author":"Kim","year":"2008","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0041","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2353\/ajpath.2008.070442","article-title":"Prion diseases: from protein to cell pathology","volume":"172","author":"Kovacs","year":"2008","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0042","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","article-title":"Benefits of metformin in attenuating the hallmarks of aging","volume":"32","author":"Kulkarni","year":"2020","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0043","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Lopez-Otin","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.671458","article-title":"The sulfation code of tauopathies: heparan sulfate proteoglycans in the prion like spread of tau pathology","volume":"8","author":"Mah","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0045","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2174\/1567205015666180223093020","article-title":"Oxidative Stress and Decreased mitochondrial superoxide dismutase 2 and peroxiredoxins 1 and 4 based mechanism of concurrent activation of AMPK and mTOR in alzheimer's disease","volume":"15","author":"Majd","year":"2018","journal-title":"Curr Alzheimer Res"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0046","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s11095-017-2199-y","article-title":"Metformin - a future therapy for neurodegenerative diseases: theme: drug discovery, development and delivery in Alzheimer's disease guest editor: Davide Brambilla","volume":"34","author":"Markowicz-Piasecka","year":"2017","journal-title":"Pharm Res"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0047","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/ncomms3192","article-title":"Metformin improves healthspan and lifespan in mice","volume":"4","author":"Martin-Montalvo","year":"2013","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0048","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.nbd.2005.05.009","article-title":"The metabolism of glycosaminoglycans is impaired in prion diseases","volume":"20","author":"Mayer-Sonnenfeld","year":"2005","journal-title":"Neurobiol Dis"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0049","first-page":"3299","article-title":"The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes","volume":"61","author":"McMahon","year":"2001","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0050","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.2174\/1570159X16666180110130253","article-title":"Understanding the role of hypoxia inducible factor during neurodegeneration for new therapeutics opportunities","volume":"16","author":"Merelli","year":"2018","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0051","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.nano.2014.03.015","article-title":"Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD","volume":"10","author":"Mizrahi","year":"2014","journal-title":"Nanomedicine"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0052","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1096\/fj.15-281675","article-title":"The inhibition of IGF-1 signaling promotes proteostasis by enhancing protein aggregation and deposition","volume":"30","author":"Moll","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0053","doi-asserted-by":"crossref","first-page":"w13917","DOI":"10.4414\/smw.2014.13917","article-title":"Selective manipulation of aging: a novel strategy for the treatment of neurodegenerative disorders","volume":"144","author":"Moll","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0054","first-page":"1","article-title":"AMPK in the brain: its roles in glucose and neural metabolism","author":"Muraleedharan","year":"2021","journal-title":"FEBS J"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0055","series-title":"Anti-aging natural compounds and their role in the regulation of metabolic pathways leading to longevity","author":"Muzammil","year":"2021"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0056","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/gerona\/glw149","article-title":"Strategies and challenges in clinical trials targeting human aging","volume":"71","author":"Newman","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0057","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbi.2017.12.009","article-title":"Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice","volume":"69","author":"Ou","year":"2018","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0058","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2174\/138920311795860188","article-title":"Glycosaminoglycans, protein aggregation and neurodegeneration","volume":"12","author":"Papy-Garcia","year":"2011","journal-title":"Curr Protein Pept Sci"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0059","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.bbamcr.2015.01.017","article-title":"Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-kappaB activation: use of insulin to attenuate metformin's effect","volume":"1853","author":"Picone","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-3-030-42667-5_13","article-title":"The use of metformin to increase the human healthspan","volume":"1260","author":"Piskovatska","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0061","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1874609810666170102144233","article-title":"Oxidative stress, pro-Inflammatory cytokines, and antioxidants regulate expression levels of MicroRNAs in parkinson's disease","volume":"10","author":"Prasad","year":"2017","journal-title":"Curr Aging Sci"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0062","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00687261","article-title":"On the biology of prions","volume":"72","author":"Prusiner","year":"1987","journal-title":"Acta Neuropathol"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0063","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s11011-020-00594-3","article-title":"Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway","volume":"35","author":"Rahimi","year":"2020","journal-title":"Metab Brain Dis"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0064","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41591-018-0087-6","article-title":"Metformin reverses established lung fibrosis in a bleomycin model","volume":"24","author":"Rangarajan","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0065","doi-asserted-by":"crossref","first-page":"150","DOI":"10.14336\/AD.2015.0820","article-title":"The role of autophagy, mitophagy and lysosomal functions in modulating bioenergetics and survival in the context of redox and proteotoxic damage: implications for neurodegenerative diseases","volume":"7","author":"Redmann","year":"2016","journal-title":"Aging Dis"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0066","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41576-018-0011-4","article-title":"Prions, prionoids and protein misfolding disorders","volume":"19","author":"Scheckel","year":"2018","journal-title":"Nat Rev Genet"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0067","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbrc.2003.10.150","article-title":"Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis","volume":"312","author":"Schonberger","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0068","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fnmol.2018.00310","article-title":"p62-Keap1-NRF2-ARE pathway: a contentious player for selective targeting of autophagy, oxidative stress and mitochondrial dysfunction in prion diseases","volume":"11","author":"Shah","year":"2018","journal-title":"Front Mol Neurosci"},{"issue":"17","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0069","doi-asserted-by":"crossref","first-page":"14324","DOI":"10.1074\/jbc.M007815200","article-title":"Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods","volume":"276","author":"Shaked","year":"2001","journal-title":"J Biol Chem"},{"issue":"5-6","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0070","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800407","article-title":"The aging metabolome-biomarkers to hub metabolites","volume":"20","author":"Sharma","year":"2020","journal-title":"Proteomics"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108183","article-title":"Metformin in COVID-19: a possible role beyond diabetes","volume":"164","author":"Sharma","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0072","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00687367","article-title":"Sulfated glycosaminoglycans in amyloid plaques of prion diseases","volume":"77","author":"Snow","year":"1989","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.09.009","article-title":"Targeting ageing and preventing organ degeneration with metformin","volume":"47","author":"Sunjaya","year":"2021","journal-title":"Diabetes Metab"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0074","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/metabo4030655","article-title":"Establishment of glycosaminoglycan assays for mucopolysaccharidoses","volume":"4","author":"Tomatsu","year":"2014","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/1673-5374.286952","article-title":"Mechanisms of neuroplasticity and brain degeneration: strategies for protection during the aging process","volume":"16","author":"Toricelli","year":"2021","journal-title":"Neural Regen Res"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0076","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1096\/fj.13-246777","article-title":"Heparin binding confers prion stability and impairs its aggregation","volume":"28","author":"Vieira","year":"2014","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0077","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00441-007-0432-4","article-title":"Immunohistological markers for staging neurogenesis in adult hippocampus","volume":"329","year":"2007","journal-title":"Cell Tissue Res"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0078","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bbapap.2016.01.008","article-title":"Roles of methionine oxidation in E200K prion protein misfolding: Implications for the mechanism of pathogenesis in E200K linked familial Creutzfeldt-Jakob disease","volume":"1864","author":"Wang","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0079","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/clinchem\/35.3.374","article-title":"Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion","volume":"35","author":"Whitley","year":"1989","journal-title":"Clin Chem"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0080","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2016.04.200","article-title":"Energy metabolism and inflammation in brain aging and Alzheimer's disease","volume":"100","author":"Yin","year":"2016","journal-title":"Free Radic Biol Med"},{"issue":"18","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0081","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1073\/pnas.0610827104","article-title":"Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans","volume":"104","author":"Yin","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurobiolaging.2021.11.001_bib0082","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6635460","article-title":"The Keap1-Nrf2 system: a mediator between oxidative stress and aging","volume":"2021","author":"Yu","year":"2021","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0083","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13258-020-01012-9","article-title":"Proteostasis-associated aging: lessons from a Drosophila model","volume":"43","author":"Yu","year":"2021","journal-title":"Genes Genomics"},{"issue":"23","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0084","doi-asserted-by":"crossref","first-page":"24270","DOI":"10.18632\/aging.202143","article-title":"Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK\/NLRP3 inflammasome pathway","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"18","key":"10.1016\/j.neurobiolaging.2021.11.001_bib0085","doi-asserted-by":"crossref","first-page":"17845","DOI":"10.18632\/aging.103693","article-title":"Metformin improves cognition of aged mice by promoting cerebral angiogenesis and neurogenesis","volume":"12","author":"Zhu","year":"2020","journal-title":"Aging (Albany NY)"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021003316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021003316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:39:25Z","timestamp":1759318765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021003316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":85,"alternative-id":["S0197458021003316"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.11.001","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing anti\u2013aging hallmark activities of Metformin and Nano-PSO in a mouse model of genetic Creutzfeldt-Jakob Disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}